Itamar Medical to Report Second Quarter Financial Results and Host Conference Call on Tuesday, August 10, 2021

Rhea-AI Summary

Itamar Medical Ltd. (NASDAQ: ITMR) will announce its financial results for Q2 2021 on August 10, 2021, before U.S. market opening. A conference call will follow at 8:00 a.m. ET, hosted by CEO Gilad Glick and CFO Shy Basson, to discuss the results and provide a corporate update. Itamar Medical specializes in non-invasive devices and solutions for diagnosing sleep disorders, offering a digital healthcare platform for effective sleep apnea management. Its key product, WatchPAT, is available in major markets including the US, Japan, and Europe.

Positive

• Scheduled financial results release on August 10, 2021, indicating transparency and communication with investors.
• Focus on sleep apnea management integrates with cardiac care, potentially expanding market reach.

Negative

• None.

CAESAREA, Israel, July 28, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management into the cardiac patient care pathway, announced today that it will report its financial results for the second quarter 2021 before the U.S. market opens on Tuesday, August 10, 2021.

The Company will host a conference call that day at 8:00 a.m. Eastern Time, 3:00 p.m. Israel Time to review financial results and provide a corporate update. The call will be hosted by Gilad Glick, President and CEO, and Shy Basson, CFO.

To listen live via webcast, please visit https://edge.media-server.com/mmc/p/4vp62jd3

To participate via phone, please use the following dial in information:
U.S. toll-free: 1-833-519-1272
International: 1-914-800-3844
Israel toll-free: 1-809-315-362
Conference ID: 3314287

Please log in approximately 10 minutes prior to the scheduled start time. The archived webcast will be available in the Events and Presentations section of the Company’s website for at least 60 days following the call.

About Itamar Medical Ltd.
Itamar Medical is a medical technology company focused on the development and commercialization of non-invasive medical devices and solutions to aid in the diagnosis of respiratory sleep disorders. Itamar Medical commercializes a digital healthcare platform to facilitate the continuum of care for effective sleep apnea management with a focus on the core sleep, cardiology and direct to consumer markets. Itamar Medical offers a Total Sleep Solution to help physicians provide comprehensive sleep apnea management in a variety of clinical environments to optimize patient care and reduce healthcare system costs. The Company’s key product, WatchPAT, is commercially available within major markets including the US, Japan, and Europe. Itamar Medical is a public company traded on the Nasdaq and on the Tel Aviv Stock Exchanges, and is based in Caesarea, Israel with U.S. headquarters based in Atlanta, GA. For additional information visit www.itamar-medical.com

Itamar Medical Investor Relations Contact (U.S.)
Leigh Salvo
Gilmartin Group
Phone: +1-415-937-5412
investors@itamar-medical.com

 

FAQ

When will Itamar Medical report its Q2 2021 financial results?

Itamar Medical will report its Q2 2021 financial results on August 10, 2021.

What time is the Itamar Medical Q2 2021 conference call?

The conference call for Itamar Medical's Q2 2021 results is scheduled for 8:00 a.m. Eastern Time on August 10, 2021.

What is Itamar Medical's focus in the healthcare market?

Itamar Medical focuses on non-invasive medical devices for diagnosing respiratory sleep disorders and managing sleep apnea.

What is the key product offered by Itamar Medical?

Itamar Medical's key product is WatchPAT, a device for sleep apnea management.